Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy

Many patients with hypertrophic cardiomyopathy have signs and symptoms of myocardial ischemia and dysfunction. Although hypertrophy and increased left ventricular pressure can account for such abnormalities, altered small intramural coronary arteries have also been described in such patients. To determine the prevalence and extent as well as the clinical relevance of abnormal intramural coronary arteries, a histologic analysis of left ventricular myocardium obtained at necropsy was performed in 48 patients with hypertrophic cardiomyopathy (but without atherosclerosis of the extramural coronary arteries) and in 68 control patients with either a normal heart or acquired heart disease. In hypertrophic cardiomyopathy, abnormal intramural coronary arteries were characterized by thickening of the vessel wall and a decrease in luminal size. The wall thickening was due to proliferation of medial or intimal components, or both, particularly smooth muscle cells and collagen. Of the 48 patients with hypertrophic cardiomyopathy, 40 (83%) had abnormalities of intramural coronary arteries located in the ventricular septum (33 patients), anterior left ventricular free wall (20 patients) or posterior free wall (9 patients); an average of 3.0 +/- 0.7 abnormal arteries were identified per tissue section. Altered intramural coronary arteries were also significantly more common in tissue sections having considerable myocardial fibrosis (31 [74%] of 42) than in those with no or mild fibrosis (31 [30%] of 102; p less than 0.001). Abnormal intramural coronary arteries were also identified in three of eight infants who died of hypertrophic cardiomyopathy before 1 year of age. In contrast, only rare altered intramural coronary arteries were identified in 6 (9%) of the 68 control patients (0.1 +/- 0.05 abnormal arteries per section; p less than 0.001) and those arteries showed only mild thickening of the wall and minimal luminal narrowing. Moreover, of those patients with abnormal intramural coronary arteries, such vessels were about 20 times more frequent in patients with hypertrophic cardiomyopathy (0.9 +/- 0.2/cm2 myocardium) than in control patients (0.04 +/- 0.02/cm2 myocardium). Hence, abnormal intramural coronary arteries with markedly thickened walls and narrowed lumens are present in increased numbers in most patients with hypertrophic cardiomyopathy studied at necropsy and may represent a congenital component of the underlying cardiomyopathic process.(ABSTRACT TRUNCATED AT 400 WORDS)

This article has been cited by other articles:

				P. Ganz and P. Y. Hsue Assessment of Structural Disease in the Coronary Microvasculature Circulation, October 20, 2009; 120(16): 1555 - 1557. [Full Text] [PDF]

				M. S. Maron, I. Olivotto, B. J. Maron, S. K. Prasad, F. Cecchi, J. E. Udelson, and P. G. Camici The case for myocardial ischemia in hypertrophic cardiomyopathy. J. Am. Coll. Cardiol., August 25, 2009; 54(9): 866 - 875. [Abstract] [Full Text] [PDF]

				D. H. Kwon, N. G. Smedira, E. R. Rodriguez, C. Tan, R. Setser, M. Thamilarasan, B. W. Lytle, H. M. Lever, and M. Y. Desai Cardiac magnetic resonance detection of myocardial scarring in hypertrophic cardiomyopathy: correlation with histopathology and prevalence of ventricular tachycardia. J. Am. Coll. Cardiol., July 14, 2009; 54(3): 242 - 249. [Abstract] [Full Text] [PDF]

				I. Olivotto, F. Cecchi, and M. H. Yacoub Myocardial bridging and sudden death in hypertrophic cardiomyopathy: Salome drops another veil Eur. Heart J., July 1, 2009; 30(13): 1549 - 1550. [Full Text] [PDF]

				W A Jaber, E H Yang, R A Nishimura, P Sorajja, C S Rihal, A Elesber, E Eeckhout, and A Lerman Immediate improvement in coronary flow reserve after alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy Heart, April 1, 2009; 95(7): 564 - 569. [Abstract] [Full Text] [PDF]

				B. J. Maron, W. C. Roberts, M. Arad, T. S. Haas, P. Spirito, G. B. Wright, A. K. Almquist, J. M. Baffa, J. P. Saul, C. Y. Ho, et al. Clinical Outcome and Phenotypic Expression in LAMP2 Cardiomyopathy JAMA, March 25, 2009; 301(12): 1253 - 1259. [Abstract] [Full Text] [PDF]

				G S Soor, A Luk, E Ahn, J R Abraham, A Woo, A Ralph-Edwards, and J Butany Hypertrophic cardiomyopathy: current understanding and treatment objectives J. Clin. Pathol., March 1, 2009; 62(3): 226 - 235. [Abstract] [Full Text] [PDF]

				A. Rudolph, H. Abdel-Aty, S. Bohl, P. Boye, A. Zagrosek, R. Dietz, and J. Schulz-Menger Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling. J. Am. Coll. Cardiol., January 20, 2009; 53(3): 284 - 291. [Abstract] [Full Text] [PDF]

				F. Cambronero, F. Marin, V. Roldan, D. Hernandez-Romero, M. Valdes, and G. Y.H. Lip Biomarkers of pathophysiology in hypertrophic cardiomyopathy: implications for clinical management and prognosis Eur. Heart J., January 9, 2009; (2009) ehn538v1. [Abstract] [Full Text] [PDF]

				C. Chimenti, E. Morgante, G. Tanzilli, E. Mangieri, G. Critelli, C. Gaudio, M. A. Russo, and A. Frustaci Angina in Fabry Disease Reflects Coronary Small Vessel Disease Circ Heart Fail, September 1, 2008; 1(3): 161 - 169. [Abstract] [Full Text] [PDF]

				B. Sotgia, R. Sciagra, I. Olivotto, G. Casolo, L. Rega, I. Betti, A. Pupi, P. G. Camici, and F. Cecchi Spatial Relationship Between Coronary Microvascular Dysfunction and Delayed Contrast Enhancement in Patients with Hypertrophic Cardiomyopathy J. Nucl. Med., July 1, 2008; 49(7): 1090 - 1096. [Abstract] [Full Text] [PDF]

				A. S. Adabag, B. J. Maron, E. Appelbaum, C. J. Harrigan, J. L. Buros, C. M. Gibson, J. R. Lesser, C. A. Hanna, J. E. Udelson, W. J. Manning, et al. Occurrence and Frequency of Arrhythmias in Hypertrophic Cardiomyopathy in Relation to Delayed Enhancement on Cardiovascular Magnetic Resonance J. Am. Coll. Cardiol., April 8, 2008; 51(14): 1369 - 1374. [Abstract] [Full Text] [PDF]

				A. C van der Wal Coronary artery pathology Heart, November 1, 2007; 93(11): 1484 - 1489. [Full Text] [PDF]

				S. E. Petersen, M. Jerosch-Herold, L. E. Hudsmith, M. D. Robson, J. M. Francis, H. A. Doll, J. B. Selvanayagam, S. Neubauer, and H. Watkins Evidence for Microvascular Dysfunction in Hypertrophic Cardiomyopathy: New Insights From Multiparametric Magnetic Resonance Imaging Circulation, May 8, 2007; 115(18): 2418 - 2425. [Abstract] [Full Text] [PDF]

				P. G. Camici and F. Crea Coronary Microvascular Dysfunction N. Engl. J. Med., February 22, 2007; 356(8): 830 - 840. [Full Text] [PDF]

				K. M. Harris, P. Spirito, M. S. Maron, A. G. Zenovich, F. Formisano, J. R. Lesser, S. Mackey-Bojack, W. J. Manning, J. E. Udelson, and B. J. Maron Prevalence, Clinical Profile, and Significance of Left Ventricular Remodeling in the End-Stage Phase of Hypertrophic Cardiomyopathy Circulation, July 18, 2006; 114(3): 216 - 225. [Abstract] [Full Text] [PDF]

				I. Olivotto, F. Cecchi, R. Gistri, R. Lorenzoni, G. Chiriatti, F. Girolami, F. Torricelli, and P. G. Camici Relevance of Coronary Microvascular Flow Impairment to Long-Term Remodeling and Systolic Dysfunction in Hypertrophic Cardiomyopathy J. Am. Coll. Cardiol., March 7, 2006; 47(5): 1043 - 1048. [Abstract] [Full Text] [PDF]

				P M Elliott, H Kindler, J S Shah, B Sachdev, O E Rimoldi, R Thaman, M T Tome, W J McKenna, P Lee, and P G Camici Coronary microvascular dysfunction in male patients with Anderson-Fabry disease and the effect of treatment with {alpha} galactosidase A Heart, March 1, 2006; 92(3): 357 - 360. [Abstract] [Full Text] [PDF]

				K S Cunningham, J P Veinot, and J Butany An approach to endomyocardial biopsy interpretation J. Clin. Pathol., February 1, 2006; 59(2): 121 - 129. [Abstract] [Full Text] [PDF]

				H. Mahrholdt, A. Wagner, R. M. Judd, U. Sechtem, and R. J. Kim Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies Eur. Heart J., August 1, 2005; 26(15): 1461 - 1474. [Abstract] [Full Text] [PDF]

				Y. Amano, S. Kumita, M. Takayama, and T. Kumazaki Comparison of Contrast-Enhanced MRI with Iodine-123 BMIPP for Detection of Myocardial Damage in Hypertrophic Cardiomyopathy Am. J. Roentgenol., August 1, 2005; 185(2): 312 - 318. [Abstract] [Full Text] [PDF]

				P. A. Kaufmann and P. G. Camici Myocardial Blood Flow Measurement by PET: Technical Aspects and Clinical Applications J. Nucl. Med., January 1, 2005; 46(1): 75 - 88. [Full Text] [PDF]

				B. Pezzulich, L. Montagna, and P. G. Lucchina Successful treatment of end-stage hypertrophic cardiomyopathy with biventricular cardiac pacing Europace, January 1, 2005; 7(4): 388 - 391. [Abstract] [Full Text] [PDF]

				R. Thaman, J. R. Gimeno, S. Reith, M. T. T. Esteban, G. Limongelli, R. T. Murphy, B. Mist, W. J. McKenna, and P. M. Elliott Progressive left ventricular remodeling in patients with hypertrophic cardiomyopathy and severe left ventricular hypertrophy J. Am. Coll. Cardiol., July 21, 2004; 44(2): 398 - 405. [Abstract] [Full Text] [PDF]

				R. Krams, F. J. Ten Cate, S. G. Carlier, A. F. W. van der Steen, and P. W. Serruys Diastolic coronary vascular reserve: a new index to detect changes in the coronary microcirculation in hypertrophic cardiomyopathy J. Am. Coll. Cardiol., February 18, 2004; 43(4): 670 - 677. [Abstract] [Full Text] [PDF]

				P. Sorajja, S. R. Ommen, R. A. Nishimura, B. J. Gersh, P. B. Berger, and A. J. Tajik Adverse Prognosis of Patients With Hypertrophic Cardiomyopathy Who Have Epicardial Coronary Artery Disease Circulation, November 11, 2003; 108(19): 2342 - 2348. [Abstract] [Full Text] [PDF]

				B. J. Maron, W. J. McKenna, G. K. Danielson, L. J. Kappenberger, H. J. Kuhn, C. E. Seidman, P. M. Shah, W. H. Spencer III, P. Spirito, F. J. Ten Cate, et al. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines J. Am. Coll. Cardiol., November 5, 2003; 42(9): 1687 - 1713. [Full Text] [PDF]

				Writing Committee Members, B. J. Maron, W. J. McKenna, G. K. Danielson, L. J. Kappenberger, H. J. Kuhn, C. E. Seidman, P. M. Shah, W. H. Spencer III, P. Spirito, et al. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy: A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines Eur. Heart J., November 1, 2003; 24(21): 1965 - 1991. [Full Text] [PDF]

				S. Isobe, H. Izawa, Y. Takeichi, M. Nonokawa, M. Nanasato, A. Ando, K. Kato, M. Ikeda, T. Murohara, and M. Yokota Relationship Between Exercise-Induced Myocardial Ischemia and Reduced Left Ventricular Distensibility in Patients with Nonobstructive Hypertrophic Cardiomyopathy J. Nucl. Med., November 1, 2003; 44(11): 1717 - 1724. [Abstract] [Full Text] [PDF]

				F. Cecchi, I. Olivotto, R. Gistri, R. Lorenzoni, G. Chiriatti, and P. G. Camici Coronary Microvascular Dysfunction and Prognosis in Hypertrophic Cardiomyopathy N. Engl. J. Med., September 11, 2003; 349(11): 1027 - 1035. [Abstract] [Full Text] [PDF]

				H. Izawa, M. Iwase, Y. Takeichi, F. Somura, K. Nagata, T. Nishizawa, A. Noda, T. Murohara, and M. Yokota Effect of Nicorandil on Left Ventricular End-Diastolic Pressure During Exercise in Patients with Hypertrophic Cardiomyopathy Eur. Heart J., July 2, 2003; 24(14): 1340 - 1348. [Abstract] [Full Text] [PDF]

				J. C. C. Moon, W. J. McKenna, J. A. McCrohon, P. M. Elliott, G. C. Smith, and D. J. Pennell Toward clinical risk assessment inhypertrophic cardiomyopathy withgadolinium cardiovascular magnetic resonance J. Am. Coll. Cardiol., May 7, 2003; 41(9): 1561 - 1567. [Abstract] [Full Text] [PDF]

				R. J. Kim and R. M. Judd Gadolinium-Enhancedmagnetic resonance imagingin hypertrophic cardiomyopathy: In vivo imaging of the pathologic substrate for premature cardiac death? J. Am. Coll. Cardiol., May 7, 2003; 41(9): 1568 - 1572. [Full Text] [PDF]

				B. J. Maron, K. P. Carney, H. M. Lever, J. F. Lewis, I. Barac, S. A. Casey, and M. V. Sherrid Relationship of race to sudden cardiac death in competitive athletes with hypertrophic cardiomyopathy J. Am. Coll. Cardiol., March 19, 2003; 41(6): 974 - 980. [Abstract] [Full Text] [PDF]

				M. S. Maron, I. Olivotto, S. Betocchi, S. A. Casey, J. R. Lesser, M. A. Losi, F. Cecchi, and B. J. Maron Effect of Left Ventricular Outflow Tract Obstruction on Clinical Outcome in Hypertrophic Cardiomyopathy N. Engl. J. Med., January 23, 2003; 348(4): 295 - 303. [Abstract] [Full Text] [PDF]

				L. Choudhury, H. Mahrholdt, A. Wagner, K. M. Choi, M. D. Elliott, F. J. Klocke, R. O. Bonow, R. M. Judd, and R. J. Kim Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy J. Am. Coll. Cardiol., December 18, 2002; 40(12): 2156 - 2164. [Abstract] [Full Text] [PDF]

				H. H. Petersen, J. Choy, B. Stauffer, F. Moien-Afshari, C. Aalkjaer, L. Leinwand, B. M. McManus, and I. Laher Coronary artery myogenic response in a genetic model of hypertrophic cardiomyopathy Am J Physiol Heart Circ Physiol, December 1, 2002; 283(6): H2244 - H2249. [Abstract] [Full Text] [PDF]

				P.P. Dimitrow and J.S. Dubiel Impairment of coronary microvascular flow in hypertrophic cardiomyopathy Eur. Heart J., June 2, 2002; 23(12): 991 - 991. [Full Text] [PDF]

				B. J. Maron Hypertrophic Cardiomyopathy: A Systematic Review JAMA, March 13, 2002; 287(10): 1308 - 1320. [Abstract] [Full Text] [PDF]

				K. Rajappan, O. E. Rimoldi, D. P. Dutka, B. Ariff, D. J. Pennell, D. J. Sheridan, and P. G. Camici Mechanisms of Coronary Microcirculatory Dysfunction in Patients With Aortic Stenosis and Angiographically Normal Coronary Arteries Circulation, January 29, 2002; 105(4): 470 - 476. [Abstract] [Full Text] [PDF]

				Y. Takeichi, M. Yokota, M. Iwase, H. Izawa, T. Nishizawa, R. Ishiki, F. Somura, K. Nagata, S. Isobe, and A. Noda Biphasic changes in left ventricular end-diastolic pressure during dynamic exercise in patients with nonobstructive hypertrophic cardiomyopathy J. Am. Coll. Cardiol., August 1, 2001; 38(2): 335 - 343. [Abstract] [Full Text] [PDF]

				M. C. Olsson, B. M. Palmer, L. A. Leinwand, and R. L. Moore Gender and aging in a transgenic mouse model of hypertrophic cardiomyopathy Am J Physiol Heart Circ Physiol, March 1, 2001; 280(3): H1136 - H1144. [Abstract] [Full Text] [PDF]

				S. A. Mohiddin, D. Begley, J. Shih, and L. Fananapazir Myocardial bridging does not predict sudden death in children with hypertrophic cardiomyopathy but is associated with more severe cardiac disease J. Am. Coll. Cardiol., December 1, 2000; 36(7): 2270 - 2278. [Abstract] [Full Text] [PDF]

				A M Varnava, P M Elliott, S Sharma, W J McKenna, and M J Davies Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease Heart, November 1, 2000; 84(5): 476 - 482. [Abstract] [Full Text]

				K. Kodama, Y. Shigematsu, M. Hamada, K. Hiwada, Y. Kazatani, K. Matsuzaki, and E. Murakami The Effect of Coronary Vasospasm on the Direction of ST-Segment Deviation in Patients With Both Hypertrophic Cardiomyopathy and Vasospastic Angina Chest, May 1, 2000; 117(5): 1300 - 1308. [Abstract] [Full Text] [PDF]

				F. Gori, C. Basso, and G. Thiene Myocardial Infarction in a Patient with Hypertrophic Cardiomyopathy N. Engl. J. Med., February 24, 2000; 342(8): 593 - 594. [Full Text]

				J. Shirani, R. Pick, W. C. Roberts, and B. J. Maron Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death J. Am. Coll. Cardiol., January 1, 2000; 35(1): 36 - 44. [Abstract] [Full Text] [PDF]

				M. Krzanowski, A. Surdacki, R. Nizankowski, A. Szczeklik, J. S. Dubiel, and P. Petkow Dimitrow Impaired Response of the Forearm Resistance but not Conductance Vessels to Reactive Hyperemia in Hypertrophic Cardiomyopathy Angiology, April 1, 1999; 50(4): 267 - 272. [Abstract] [PDF]

				N. Kawada, H. Sakuma, T. Yamakado, K. Takeda, N. Isaka, T. Nakano, and C. B. Higgins Hypertrophic Cardiomyopathy: MR Measurement of Coronary Blood Flow and Vasodilator Flow Reserve in Patients and Healthy Subjects Radiology, April 1, 1999; 211(1): 129 - 135. [Abstract] [Full Text]

				L.J. Kappenberger, C. Linde, X. Jeanrenaud, C. Daubert, W. McKenna, E. Meisel, N. Sadoul, L. Chojnowska, L. Guize, D. Gras, et al. Clinical progress after randomized on/off pacemaker treatment for hypertrophic obstructive cardiomyopathy Europace, January 1, 1999; 1(2): 77 - 84. [Abstract] [PDF]

				N. Yoshida, H. Ikeda, T. Wada, A. Matsumoto, S. Maki, A. Muro, A. Shibata, and T. Imaizumi Exercise-induced abnormal blood pressure responses are related to subendocardial ischemia in hypertrophic cardiomyopathy J. Am. Coll. Cardiol., December 1, 1998; 32(7): 1938 - 1942. [Abstract] [Full Text] [PDF]

				B. J. Maron, J. H. Moller, C. E. Seidman, G. M. Vincent, H. C. Dietz, A. J. Moss, J. A. Towbin, H. M. Sondheimer, R. E. Pyeritz, G. McGee, et al. Impact of Laboratory Molecular Diagnosis on Contemporary Diagnostic Criteria for Genetically Transmitted Cardiovascular Diseases: Hypertrophic Cardiomyopathy, Long-QT Syndrome, and Marfan Syndrome : A Statement for Healthcare Professionals From the Councils on Clinical Cardiology, Cardiovascular Disease in the Young, and Basic Science, American Heart Association Circulation, October 6, 1998; 98(14): 1460 - 1471. [Full Text] [PDF]

				M. Hamada, Y. Kazatani, K. Matsuzaki, E. Murakami, Y. Shigematsu, K. Hiwada, and K. Kodama Clinical Characteristics in Japanese Patients with Coexistent Hypertrophic Cardiomyopathy and Coronary Vasospasm Angiology, September 1, 1998; 49(9): 849 - 855. [Abstract] [PDF]

				Y Okajima, Y Tanabe, M Takayanagi, and H Aotsuka A follow up study of myocardial involvement in patients with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) Heart, September 1, 1998; 80(3): 292 - 295. [Abstract] [Full Text]

				T. Hirayama, K. Marumoto, H. Okayama, T. Iwata, and M. Suzuki Paroxysmal Atrial Fibrillation as a Cause of Potentially Lethal Ventricular Arrhythmia with Myocardial Ischemia in Hypertrophic Cardiomyopathy: A Case Report Angiology, August 1, 1998; 49(8): 653 - 657. [Abstract] [PDF]

				S. Gielen, R. H. Strasser, W. Kubler, and C. Haller Coronary Artery Ectasia and Systolic Flow Cessation in Hypertrophic Cardiomyopathy Circulation, June 16, 1998; 97(23): 2372 - 2374. [Full Text] [PDF]

				K. L. Vikstrom, T. Bohlmeyer, S. M. Factor, and L. A. Leinwand Hypertrophy, Pathology, and Molecular Markers of Cardiac Pathogenesis Circ. Res., April 20, 1998; 82(7): 773 - 778. [Abstract] [Full Text] [PDF]

				R. Krams, M. J. M. Kofflard, D. J. Duncker, C. Von Birgelen, S. Carlier, M. Kliffen, F. J. t. Cate, and P. W. Serruys Decreased Coronary Flow Reserve in Hypertrophic Cardiomyopathy Is Related to Remodeling of the Coronary Microcirculation Circulation, January 27, 1998; 97(3): 230 - 233. [Abstract] [Full Text] [PDF]

				M. Schafers, D. Dutka, C. G. Rhodes, A. A. Lammertsma, F. Hermansen, O. Schober, and P. G. Camici Myocardial Presynaptic and Postsynaptic Autonomic Dysfunction in Hypertrophic Cardiomyopathy Circ. Res., January 23, 1998; 82(1): 57 - 62. [Abstract] [Full Text] [PDF]

				G Takemura, Y Takatsu, and H Fujiwara Luminal narrowing of coronary capillaries in human hypertrophic hearts: an ultrastructural morphometrical study using endomyocardial biopsy specimens Heart, January 1, 1998; 79(1): 78 - 85. [Abstract] [Full Text] [PDF]

				E. Lazzeroni, E. Picano, L. Morozzi, A. R. Maurizio, G. Palma, R. Ceriati, E. Iori, and A. Barilli Dipyridamole-Induced Ischemia as a Prognostic Marker of Future Adverse Cardiac Events in Adult Patients With Hypertrophic Cardiomyopathy Circulation, December 16, 1997; 96(12): 4268 - 4272. [Abstract] [Full Text]

				P. Spirito, C. E. Seidman, W. J. McKenna, and B. J. Maron The Management of Hypertrophic Cardiomyopathy N. Engl. J. Med., March 13, 1997; 336(11): 775 - 785. [Full Text] [PDF]

				W. M. Chilian Coronary Microcirculation in Health and Disease: Summary of an NHLBI Workshop Circulation, January 21, 1997; 95(2): 522 - 528. [Abstract] [Full Text]

				P. R. Fox, S.-K. Liu, and B. J. Maron Echocardiographic Assessment of Spontaneously Occurring Feline Hypertrophic Cardiomyopathy : An Animal Model of Human Disease Circulation, November 1, 1995; 92(9): 2645 - 2651. [Abstract] [Full Text]

				D C Lefroy Grand Rounds - Hammersmith Hospital: Cardiac arrest and hypertrophic cardiomyopathy BMJ, November 12, 1994; 309(6964): 1277 - 1279. [Full Text]

				S. Okamoto, M. Ozaki, T. Konishi, and T. Nakano A Case Report of Siblings with Hypertrophic Cardiomyopathy that Progressed to Dilated Cardiomyopathy-Case Reports Angiology, May 1, 1993; 44(5): 406 - 411. [Abstract] [PDF]